Pharmaceutical industry strategic partner of the country

ROME – There is no future without health. This was reiterated by the president of Farmindustria, Massimo Scaccabarozzi, opening the public assembly 2021. “The pandemic has taught us many things, including how fragile we are and how necessary is the ability to prevent and manage a collective emergency. ? Redesigning the health of the future, all together. There is no future without health. Health – he underlined – implies research, digitalization, advanced robotics, ecological transition, quality work, continuous training and investment in the new generations, cohesion Farmindustria in this context has been a useful link between pharmaceutical companies and authorities, to facilitate an internal synthesis and help the decision-maker to combine the particular interest with the general one “. Scaccabarozzi explained that “the pharmaceutical industry is not just research, production and distribution but also carries out, in partnership with institutions and professions, processes and services dedicated to public health and the personalization of individual patient care. Our companies have guaranteed drugs for all diseases. And they committed themselves to the development of anti-Covid vaccines and, in the absence of guarantees that they would be approved, they produced them at their own risk during the experimentation “. For the president of Farmindustria, the pandemic has taught us that we need to strengthen medicine in the territory: “Italy is fortunate to have a universal NHS, recognized in the Constitution, which must be unified with respect to regional diversities, strengthened in territorial services and adequate to the criteria of taking charge and continuity of care. The primary objective must be to bring innovation closer to the patient in every part of the territory. We have proposed to continue this collaboration by activating thematic tables with the Health Commission “. Italy must now bet everything on the PNRR. “The necessary funding for the reengineering of the NHS and for investments in the health sector can now arrive from the NRP. There are 1,500 billion dollars ready to be invested in research in the world from 2020 to 2026. The value of almost seven NRPs; I believe that we must feel the full responsibility of attracting them to Italy as much as possible “, he added. “We have 4.6 billion of additional investments ready in three years, in production and research, with projects that can easily be set up that could bring 8,000 new jobs in our companies alone. Italy – concluded Scaccabarozzi – is a reservoir of resources and excellence in life sciences “. The Minister of Economic Development, Giancarlo Giorgetti, assured that “the Government will implement all the measures to strengthen the sector and we are aware that public support is necessary. The Italian pharmaceutical industry is important, it has also held in the 2020, but there are also shadows if we look at the amount of research resources “. The Minister for Regional Affairs, Mariastella Gelmini, invited everyone to work together. “In this year and a half we have supported a model of public and private partnership, a modality that we must claim and continue, we need a great team effort, we must all row in the same direction. We are all waiting for the creation of an Italian vaccine, we have touched the importance of automatically producing drugs and protective devices, the government is committed to strengthening this goal. During the pandemic we rediscovered the value of health, the centrality in investment for research, health. Now we have to run on vaccinations. The key word for building the future is that of a new pact of trust between state and citizens “. The Minister of Health, Roberto Speranza, thanked the companies involved in these 18 months of pandemic: “We have lived through difficult months and I can confirm that the Italian industry has been there. We have been able to count on you on your skills, on your professionalism “, announcing that” we are at a decisive junction of the junction of our NHS, the challenge is to manage the epidemic and overturn the crisis in an opportunity, investing in the National Health Service is the first node if we want to open a different season, the cutting season has ended, and the investment season has begun “. The president of Confindustria, Carlo Bonomi acknowledged that “without your companies the world would never have won the challenge at Covid, we must perform a great informational task to avoid wrong assessments. I must acknowledge that in the pandemic the Italian pharmaceutical industry has proven itself at the height of its fame, the health sector represents a driving force for economic and social growth, we must translate this heritage in the best possible way, but there are many reforms that must be made “. . ror / ads / mgg / red 08-Jul-21 17:45